Fundraising Fox
eterna tear
Raleigh, US · Founded 2018 · 11 known investors
Find your way into eterna tear
Sign up to see every warm intro you have to eterna tear
- Paths you didn't know you had: your email and LinkedIn already hold routes to the eterna tear team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction. The company is founded by experienced ophthalmology and medical device leaders with extensive track records in bringing dry eye treatments to market.
Founders & leadership
Investors · 11
How we know: Arieal Southeast Angel Partners's portfolio page · Not right? Tell us
How we know: Charlotte Angel Fund's portfolio page · Not right? Tell us
How we know: Kleinmuntz Associates's portfolio page · Not right? Tell us
How we know: funding news · deepworkcapital.com · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 1 round · 2020
▶$4.9MraisedDec 2020 · 45 investors · BiotechnologyRule 506(b)
- Timothy WillisExecutive Officer, Director
- Diethart ReichardtExecutive Officer, Director
- Kent GeerExecutive Officer
- Offering amount
- $4.9M
- Amount sold
- $4.9M
- Minimum investment
- $5K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does eterna tear do?
- Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction. The company is founded by experienced ophthalmology and medical device leaders with extensive track records in bringing dry eye treatments to market.
- Who are eterna tear's investors?
- eterna tear's investors include Arieal Southeast Angel Partners, Charlotte Angel Fund, Duke Capital Partners, Kleinmuntz Associates, Band of Angels, Carolina Angel Network, DeepWork Capital, Keiretsu Capital and 1 more.
- How much funding has eterna tear raised?
- eterna tear has disclosed $4.9M raised across 1 round.
- Where is eterna tear headquartered?
- eterna tear is headquartered in Raleigh, US.